Chapman J, Ben-Israel J, Goldhammer Y, Korczyn A D
Department of Neurology, Tel Aviv Medical Center, Israel.
Neurology. 1994 Sep;44(9):1683-6. doi: 10.1212/wnl.44.9.1683.
We determined the penetrance of the PRNP 200Lys mutation in the large cluster of Creutzfeldt-Jakob disease (CJD) cases among Jews of Libyan-Tunisian origin living in Israel, utilizing data from 52 carriers with definite or probable CJD and 34 unaffected mutation carriers. A life table analysis was carried out with development of CJD as the end point. The probability of developing CJD rose with age, fitting a second-order regression curve (R = 0.97, p < 0.001). The cumulative penetrance reached 50% at the age of 60 and 80% at 80 years. Including seven elderly possible CJD patients in the analysis made the penetrance approach 100% by age eighty. The penetrance of the mutation is high, and although age is a predominant influencing factor, other factors, such as gender, may also play a role.
我们利用来自52例确诊或疑似克雅氏病(CJD)患者及34例未发病的突变携带者的数据,确定了居住在以色列的利比亚 - 突尼斯裔犹太人中克雅氏病(CJD)大聚集病例群中PRNP 200Lys突变的外显率。以CJD发病为终点进行了生存分析。患CJD的概率随年龄增长而上升,符合二次回归曲线(R = 0.97,p < 0.001)。累积外显率在60岁时达到50%,80岁时达到80%。分析中纳入7例老年疑似CJD患者后,到80岁时外显率接近100%。该突变的外显率很高,虽然年龄是主要影响因素,但其他因素,如性别,也可能起作用。